155.90CHF+0.32%Mkt Cap: 1.97B CHFP/E: —Last update: 2026-06-01
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap1.97B CHF
Enterprise Value1.85B CHF
Revenue (TTM)882.48M CHF
Gross Profit310.84M CHF
Net Income (TTM)-110.65M CHF
Revenue/Share69.69 CHF
Last Price155.90 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)20.54
PEG1.71
EV/EBITDA22.93
EV/Revenue2.10
P/S2.23
P/B1.69
EPS (TTM)-8.86
EPS (Forward)7.57
52W Range
110.6068% of range177.50
52W High177.50 CHF
52W Low110.60 CHF
Profitability
Gross Margin35.22%
Oper. Margin4.93%
EBITDA Margin9.16%
Profit Margin-12.54%
ROE-9.61%
ROA-6.52%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF137.98M CHF
CapEx (TTM)35.30M CHF
FCF Margin12.86%
FCF Yield5.75%
Net Debt-93.05M CHF
Net Debt/EBITDA-1.15
Balance Sheet
Debt/Equity0.19
Current Ratio2.46
Quick Ratio1.69
Book Value/Sh91.87 CHF
Cash/Share24.84 CHF
Dividends
Fwd Div Rate3.000 CHF
Trail. Div Rate3.000 CHF
Div. Yield1.93%
5Y Avg Yield1.14%
Payout Ratio60.61%
Ex-Div DateApr 17, 2026
Pay DateApr 16, 2025
Analyst Consensus
Rating2.4 (Buy)
Target (Mean)165.47 CHF
Target Range136.00 CHF – 205.00 CHF
# Analysts8
Ownership
Shares Out.12.66M
Float12.50M
Insiders0.43%
Institutions63.04%
Technical
SMA 50133.23 (+17.0%)
SMA 200139.68 (+11.6%)
Beta1.01
S&P 52W Chg27.70%
Avg Vol (30d)56.58K
Avg Vol (10d)54.70K
Technical Indicators
RSI (14)75.2
MACD6.2238
MACD Signal4.1241
MACD Hist.+2.0997
BB Upper160.52 CHF
BB Middle137.13 CHF
BB Lower113.73 CHF
BB Width34.12%
ATR (14)5.164 CHF
Vol Ratio (20d)1.06x